Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline

Neurology

Volumn 72, Issue 4, 2009, Pages 361-367

  Tangney, Christine C ^a,e   Tang, Yuxiao ^b,d   Evans, Denis A ^a,b,c   Morris, Martha Clare ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d PATH   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE; METHYLMALONIC ACID; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; FOLIC ACID;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; COGNITIVE DEFECT; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; VITAMIN BLOOD LEVEL; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; RISK FACTOR;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COGNITION DISORDERS; COHORT STUDIES; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; INDICATORS AND REAGENTS; MALE; METHYLMALONIC ACID; RISK FACTORS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 60549117481     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000341272.48617.b0     Document Type: Article

References (40)

1. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 2005;82:442-450.
2. Department of Health. London: Scientific Advisory Committee on Nutrition; 2006.
3. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007;85: 193-200.
4. 12 intake and cognitive decline among community-dwelling older persons. Arch Neurol 2005;62: 641-645.
5. Ravaglia G, Forti P, Maioli F, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005;82:636-643.
6. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
7. Clarke R, Birks J, Nexo E, et al. Low vitamin B-12 status and risk of cognitive decline in older adults. Am J Clin Nutr 2007;86:1384-1391.
8. Bienias JL, Beckett LA, Bennett DA, Wilson RS, Evans DA. Design of the Chicago Health and Aging Project (CHAP). J Alzheimer Dis 2003;5:349-355.
9. 12) and folate deficiency. FASEB J 1993;7:1344-1353.
10. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Elevation of 2-methylcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism 1993;42:978-988.
11. Stabler SP, Lindenbaum J, Savage DG, Allen RH. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 1993;81:3404-3413.
12. Albert MS, Smith LA, Scherr PA. Use of brief cognitive tests to identify individuals in the community with clinically-diagnosed Alzheimer's disease. Intl J Neurosci 1991;57:167-178.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
14. Smith A. Symbol Digit Modalities Test Manual - Revised. Los Angeles, CA: Western Psychological; 1984.
15. Wilson RS, Bennett DA, Beckett LA, et al. Cognitive activity in older persons from a geographically defined population. J Gerontol B Psychol Sci Soc Sci 1999;54: P155-P160.
16. Morris MC, Colditz GA, Evans DA. Response to a mail nutritional survey in an older bi-racial community population. Ann Epidemiol 1998;8:342-346.
17. Willett WC. Total energy intake and nutrient composition: dietary recommendations for epidemiologists. Int J Cancer 1990;46:770-771.
18. Laird NM, Ware JH. Random effects models for longitudinal data. Biometrics 1982;38:963-974.
19. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. Fish consumption and cognitive decline with age in a large community study. Arch Neurol 2005;62: 1849-1853.
20. Morris MC, Evans DA, Bienias JL, et al. Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline. J Neurol Neurosurg Psychiatry 2004;75:1093-1099.
21. Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 2004;62: 1573-1579.
22. Nilsson-Ehle H. Age-related changes in cobalamin (vitamin B12) handling: implications for therapy. Drugs Aging 1998;12:277-292.
23. Stabler S, Lindenbaum J, Allen R. Vitamin B-12 deficiency in the elderly: current dilemmas. Am J Clin Nutr 1997;66:741-749.
24. Saperstein DS, Wolfe GI, Gronseth GS, et al. Challenges in the identification of cobalamin-deficiency polyneuropathy. Arch Neurol 2003;60:1296-1301.
25. Martin DC, Francis J, Protetch J, Huff FJ. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 1992;40:168-172.
26. Mooijaart SP, Gussekloo J, Frolich M, et al. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study. Am J Clin Nutr 2005;82:866-871.
27. 12, and cognitive function and decline. Epidemiology 2006;17:650-657.
28. 12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med 2005;118:161-167.
29. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A, 3rd. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 2005;82:627-635.
30. 12 study. Age Ageing 2006;35:416-422.
31. Pfeiffer CM, Osterloh JD, Kennedy-Stephenson J, et al. Trends in circulation concentrations of total homocysteine among US adolescents and adults: findings from the 1991-1994 and 1999-2004 National Health and Nutrition Examination Surveys. Clin Chem 2008;54:1-12.
32. Haan MN, Miller JW, Aiello AE, et al. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2007;85:511-517.
33. Dufouil C, Alperovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003;53:214-221.
34. Durga J, van Boxtel MP, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007;369:208-216.
35. Stott DJ, MacIntosh G, Lowe GD, et al. Randomized controlled trial of homocysteine lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr 2005;82:1320-1326.
36. McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, Williams SM. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006;354: 2764-2772.
37. Lewerin C, Matousek M, Steen G, Johanssen B, Steen B, Nilsson-Ehle H. Significant correlations of plasma homocysteine and serum methylmalonic acid with movement. Am J Clin Nutr 2005;81:155-162.
38. McCracken C, Hudson P, Ellis R, McCaddon A. Medical Research Council Cognitive Function and Ageing Study: methylmalonic acid and cognitive function in the Medical Research Council Cognitive Function and Ageing Study. Am J Clin Nutr 2006;84:1406-1411.
39. Lewis MS, Miller LS, Johnson MA, Dolce EB, Allen RH, Stabler SP. Elevated methylmalonic acid is related to cognitive impairment in older adults enrolled in an elderly nutrition program. J Nutr Elderly 2005;24:47-65.
40. Garcia AA, Haron Y, Evans LR, Smith MG, Freedman M, Roman GC. Metabolic markers of cobalamin deficiency and cognitive function in normal older adults. J Am Geriatr Soc 2004;52:66-71.